140 related articles for article (PubMed ID: 28238806)
1. Rat acute GvHD is Th1 driven and characterized by predominant donor CD4
Boieri M; Shah P; Jalapothu D; Zaitseva O; Walter L; Rolstad B; Naper C; Dressel R; Inngjerdingen M
Exp Hematol; 2017 Jun; 50():33-45.e3. PubMed ID: 28238806
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.
Yi T; Chen Y; Wang L; Du G; Huang D; Zhao D; Johnston H; Young J; Todorov I; Umetsu DT; Chen L; Iwakura Y; Kandeel F; Forman S; Zeng D
Blood; 2009 Oct; 114(14):3101-12. PubMed ID: 19602708
[TBL] [Abstract][Full Text] [Related]
3. PIAS3 suppresses acute graft-versus-host disease by modulating effector T and B cell subsets through inhibition of STAT3 activation.
Lee SH; Moon SJ; Park MJ; Kim EK; Moon YM; Cho ML
Immunol Lett; 2014 Jul; 160(1):79-88. PubMed ID: 24718277
[TBL] [Abstract][Full Text] [Related]
4. Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease.
Brüggen MC; Klein I; Greinix H; Bauer W; Kuzmina Z; Rabitsch W; Kalhs P; Petzelbauer P; Knobler R; Stingl G; Stary G
Blood; 2014 Jan; 123(2):290-9. PubMed ID: 24255916
[TBL] [Abstract][Full Text] [Related]
5. [The role of CD4+ CD25+ T cell and FOXP3 in hsot acute graft rejection].
Liu YJ; Wu DP; Li CX; He J; Qiu QC; Zhang XG
Zhonghua Nei Ke Za Zhi; 2006 Oct; 45(10):835-8. PubMed ID: 17217750
[TBL] [Abstract][Full Text] [Related]
6. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.
Yi T; Zhao D; Lin CL; Zhang C; Chen Y; Todorov I; LeBon T; Kandeel F; Forman S; Zeng D
Blood; 2008 Sep; 112(5):2101-10. PubMed ID: 18596226
[TBL] [Abstract][Full Text] [Related]
7. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
Johnson BD; Becker EE; Truitt RL
Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of interleukin-18 receptor on T lymphocytes in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation.
Fujimori Y; Yoshimoto T; Matsui K; Tsutsui H; Okamoto T; Kashiwamura S; Hada T; Okamura H; Kakishita E; Hara H; Nakanishi K
J Interferon Cytokine Res; 2002 Jul; 22(7):751-4. PubMed ID: 12184912
[TBL] [Abstract][Full Text] [Related]
9. Fluctuations in pathogenic CD4+ T-cell subsets in a murine sclerodermatous model of chronic graft-versus-host disease.
Lim JY; Cho BS; Min CK; Park G; Kim YJ; Chung NG; Jeong DC; Min WS
Immunol Invest; 2014; 43(1):41-53. PubMed ID: 24111544
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
[TBL] [Abstract][Full Text] [Related]
11. Donor-Derived Regulatory T Cells Attenuate the Severity of Acute Graft-Versus-Host Disease after Cord Blood Transplantation.
Zou X; Lin X; Luo W; Wei J
Tohoku J Exp Med; 2016 Jul; 239(3):193-202. PubMed ID: 27356468
[TBL] [Abstract][Full Text] [Related]
12. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
13. Differential upregulation of interleukin-18 receptor alpha chain between CD4+ and CD8+ T cells during acute graft-versus-host disease in mice.
Itoi H; Fujimori Y; Tsutsui H; Matsui K; Hada T; Kakishita E; Okamura H; Hara H; Nakanishi K
J Interferon Cytokine Res; 2004 May; 24(5):291-6. PubMed ID: 15153312
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells.
Rus V; Svetic A; Nguyen P; Gause WC; Via CS
J Immunol; 1995 Sep; 155(5):2396-406. PubMed ID: 7650373
[TBL] [Abstract][Full Text] [Related]
15. Donor-derived IL-17A and IL-17F deficiency triggers Th1 allo-responses and increases gut leakage during acute GVHD.
Odak I; Depkat-Jakob A; Beck M; Jarek M; Yu Y; Seidler U; David S; Ganser A; Förster R; Prinz I; Koenecke C
PLoS One; 2020; 15(4):e0231222. PubMed ID: 32251446
[TBL] [Abstract][Full Text] [Related]
16. T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?
Campe J; Ullrich E
Front Immunol; 2021; 12():806529. PubMed ID: 35069590
[TBL] [Abstract][Full Text] [Related]
17. Homing in on acute graft vs. host disease: tissue-specific T regulatory and Th17 cells.
Engelhardt BG; Crowe JE
Curr Top Microbiol Immunol; 2010; 341():121-46. PubMed ID: 20563712
[TBL] [Abstract][Full Text] [Related]
18. IL-17-producing T cells contribute to acute graft-versus-host disease in patients undergoing unmanipulated blood and marrow transplantation.
Zhao XY; Xu LL; Lu SY; Huang XJ
Eur J Immunol; 2011 Feb; 41(2):514-26. PubMed ID: 21268020
[TBL] [Abstract][Full Text] [Related]
19. Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cells.
Murphy GF; Whitaker D; Sprent J; Korngold R
Am J Pathol; 1991 Apr; 138(4):983-90. PubMed ID: 1901455
[TBL] [Abstract][Full Text] [Related]
20. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
